Stockscreener 앱 받기
18.73
0.16%
-0.03
시간 외 거래:
18.73
Zimvie Inc 주식(ZIMV)의 최신 뉴스
ZIMVIE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ZimVie Inc.ZIMV - The Globe and Mail
Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers - insights.citeline.com
What drives ZimVie Inc. stock priceExplosive portfolio gains - jammulinksnews.com
ARCHIMED To Buy ZimVie In $730 Million Deal - Pulse 2.0
ZimVie upgraded to Equal Weight from Underweight at Barclays - TipRanks
ZimVie to sell to investment firm for about $730M - MedTech Dive
Barclays upgrades ZimVie stock rating to Equalweight on Archimed merger - Investing.com Australia
What analysts say about ZimVie Inc. stockHigh-yield portfolio picks - jammulinksnews.com
Dental Implants and Prosthetics Market is projected to reach US$ - openPR.com
ARCHIMED to acquire life sciences company ZimVie for $730m - Yahoo Finance
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan - MSN
Latham & Watkins Advises ARCHIMED in US$730 Million Acquisition of ZimVie Inc. - Latham & Watkins LLP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.
ZimVie Inc. Stock Analysis and ForecastSuperior trading gains - jammulinksnews.com
ZimVie Sells For $730 Million In Archimed Buyout - Finimize
ArchiMed To Acquire ZimVie in $730M Deal - USA Herald
Latham And Cravath Steer $730M ZimVie Take-Private Deal - Law360
ZimVie Acquired by Archimed Affiliate for $730 Million, Going Private - Medical Device and Diagnostic industry
Small Medtech Catapults 122% On Its Second Takeover Deal - Investor's Business Daily
ZimVie to be acquired by Archimed in $730M deal - MassDevice
ZimVie stock soars after $730 million acquisition deal with ARCHIMED By Investing.com - Investing.com Canada
ZimVie stock soars after $730 million acquisition deal with ARCHIMED - Investing.com India
The ZimVie Takeover: A Strategic Bet on Dental Innovation and MedTech Consolidation - AInvest
Hold Rating Maintained on ZimVie Inc Amid Acquisition by ARCHIMED - TipRanks
ZimVie's $730M Take-Private by Archimed: A Strategic Exit and Value Realization Opportunity - AInvest
Shareholder Alert: The Ademi Firm investigates whether ZimVie Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
Dental devicemaker ZimVie to be bought by ArchiMed in $730M deal - Fierce Biotech
ZimVie shares surge after go-private deal with Archimed - TradingView
ZimVie to be acquired by ARCHIMED in $730 million deal - Investing.com
ZIMV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ZimVie Inc. Is Fair to Shareholders - Business Wire
ZimVie Stock (ZIMV) Rockets 120% on ARCHIMED Deal - TipRanks
ZimVie Stock Soars 121.92% on ARCHIMED Acquisition Deal - AInvest
ZimVie to be acquired by ARCHIMED for $19.00 per share in cash - TipRanks
ZimVie Inc to be Acquired by ARCHIMED - TipRanks
ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash - The Manila Times
Dental Tech Leader ZimVie Gets Massive 99% Premium in $730M ARCHIMED Buyout Deal - Stock Titan
Is ZimVie Inc. a good long term investmentSuperior return velocity - Autocar Professional
How ZimVie Inc. stock performs during market volatilitySolid Return Trade Selections - Newser
1.64%
0.34%
자본화:
|
볼륨(24시간):